Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19147,920,0.84 [0.72-0.98],0.0247720907032768
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,18387,291,0.83 [0.63-1.09],0.1789988989817907
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,21702,181,0.82 [0.59-1.15],0.2480170740959594
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,13450,1089,0.64 [0.55-0.75],6.275509843752267e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21656,135,0.83 [0.56-1.22],0.3380054643303192
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,19198,96,1.11 [0.70-1.78],0.6563877143288184
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23127,134,0.86 [0.58-1.26],0.4327653318703549
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23114,90,0.78 [0.49-1.26],0.3125405406499101
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,18701,73,0.83 [0.49-1.41],0.4933302772144686
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,21961,133,1.13 [0.76-1.68],0.5404384303350255
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other septicaemia,21916,88,1.18 [0.72-1.92],0.505801754179215
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23235,69,1.21 [0.70-2.11],0.4983105774830678
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23268,68,1.11 [0.64-1.92],0.7229142867270766
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23265,65,1.05 [0.60-1.85],0.8681041251043082
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Mycoses,22761,61,0.88 [0.49-1.57],0.6587958571247243
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",21637,441,0.84 [0.67-1.04],0.1149242245341415
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21335,139,0.78 [0.53-1.14],0.202478880343475
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,21516,320,0.87 [0.68-1.13],0.3003300824807129
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",16733,103,0.73 [0.47-1.13],0.1556032004758454
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16694,64,nan [nan-nan],
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",17035,405,0.79 [0.63-0.99],0.0397142736000159
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",17047,417,0.80 [0.64-1.01],0.0568437979312108
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",9563,384,1.05 [0.82-1.34],0.7173679907048872
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",7660,209,0.94 [0.67-1.31],0.7063062582983495
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16687,57,1.29 [0.71-2.35],0.4077548388718282
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19871,781,1.02 [0.87-1.21],0.7775181012265817
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",21724,473,0.85 [0.69-1.05],0.1410802818184506
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,22731,158,0.89 [0.62-1.28],0.5378898499676326
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23321,152,0.79 [0.55-1.14],0.2161002665125345
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Rectum,22996,86,0.74 [0.46-1.20],0.2231989198775066
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23329,97,0.72 [0.46-1.15],0.1698262748512241
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Stomach,23384,71,0.73 [0.43-1.26],0.2617148674099087
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm,23144,297,0.95 [0.73-1.23],0.686689713763788
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23365,102,1.53 [0.98-2.40],0.0631234164463126
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23371,85,1.11 [0.67-1.82],0.6929048290148082
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23282,59,1.89 [1.04-3.42],0.0356994112300623
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Haemangioma, any site",23285,58,1.94 [1.07-3.53],0.0294007228752932
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Melanocytic naevi,23223,149,1.28 [0.88-1.86],0.2015698538543205
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23362,64,1.29 [0.73-2.28],0.3876380427622556
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Other benign neoplasms of skin,23241,177,1.09 [0.77-1.54],0.6312748884999909
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm of breast,12195,44,1.87 [0.93-3.79],0.0807161759088019
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Leiomyoma of uterus,12049,309,0.84 [0.64-1.10],0.2041585294966003
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,21790,197,0.83 [0.60-1.15],0.2661249526001777
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,21249,359,0.92 [0.72-1.17],0.479523825712009
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,21249,359,0.92 [0.72-1.17],0.479523825712009
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),18667,573,0.75 [0.62-0.91],0.0029745104252208
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22761,59,1.47 [0.81-2.70],0.2066922804395035
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23034,63,0.77 [0.44-1.36],0.3756513160283058
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,16908,1665,0.55 [0.49-0.62],2.5211422104608777e-22
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,21632,648,1.51 [1.26-1.81],1.0494096933179556e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,20550,157,0.65 [0.45-0.93],0.0198544202387703
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21753,170,0.45 [0.32-0.63],3.618096799560239e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20536,143,0.62 [0.42-0.91],0.0151406351883452
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,21178,785,0.49 [0.41-0.58],3.25420544487794e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,21152,759,0.47 [0.40-0.56],2.6423962866257377e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,21478,189,0.69 [0.47-1.00],0.04856045138825
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",21477,188,0.69 [0.47-1.00],0.0489432405939298
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,16725,1482,0.52 [0.46-0.59],4.623224362809472e-24
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15435,192,0.55 [0.40-0.76],0.0003364158339628
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,16615,1372,0.52 [0.45-0.59],1.7267852381326985e-23
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15300,57,0.94 [0.51-1.73],0.8434913178332807
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",15334,91,0.72 [0.45-1.16],0.1770611274461559
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Any mental disorder,19135,544,0.73 [0.60-0.89],0.0020837670069547
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",18753,162,0.56 [0.39-0.79],0.0011536212255188
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23013,114,0.67 [0.44-1.02],0.062191916136101
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23074,85,0.71 [0.44-1.16],0.1692245867790227
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,21815,34,0.55 [0.26-1.16],0.1165106545685585
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23304,34,0.61 [0.29-1.31],0.2064275943258238
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",18625,34,0.53 [0.25-1.11],0.0933485090406165
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Alcohol dependence,21823,42,0.51 [0.26-0.99],0.0463431633981338
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Smoking dependency,21748,50,0.49 [0.27-0.92],0.0249758260698137
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18627,36,0.51 [0.25-1.06],0.0697421128004626
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",18855,264,0.77 [0.58-1.02],0.0693954765374911
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Depression,21906,234,0.83 [0.61-1.11],0.2072107756710001
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Depression or dysthymia,18491,201,0.80 [0.58-1.10],0.1704035827543254
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",18702,111,0.95 [0.62-1.47],0.8268810335496448
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Other anxiety disorders,21962,64,1.13 [0.64-2.00],0.6664406615216636
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Neurological diseases,18995,1516,0.76 [0.68-0.86],1.781441191828561e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,16615,106,0.60 [0.39-0.93],0.0233576176770414
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23289,81,0.70 [0.43-1.15],0.1552360819123305
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22037,476,0.64 [0.52-0.79],2.588356468507328e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Epilepsy,21697,136,0.84 [0.57-1.24],0.3806210713150664
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Migraine,21620,59,0.89 [0.49-1.61],0.688494188821535
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23147,53,0.88 [0.47-1.64],0.6812603060577133
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22195,120,0.47 [0.32-0.70],0.000158288795883
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other sleep disorders,21722,161,0.57 [0.40-0.82],0.0022359262935565
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Sleep apnoea,22845,120,0.51 [0.34-0.77],0.0011326617002976
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22162,723,1.06 [0.89-1.26],0.5100020581629348
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21545,106,0.98 [0.63-1.52],0.9255788659046048
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21883,444,1.24 [1.00-1.55],0.0552418927662611
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,22995,79,0.50 [0.30-0.81],0.0049782401581421
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Hemiplegia,22976,60,0.56 [0.32-0.98],0.0423928376760848
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other neurological diseases,22820,121,0.69 [0.46-1.04],0.0794056766455355
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22512,428,1.00 [0.80-1.24],0.978588493309342
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22343,259,0.90 [0.68-1.20],0.4754809369342605
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22146,62,0.95 [0.53-1.69],0.8630497609989776
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22221,137,1.09 [0.74-1.61],0.67324521575747
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22191,107,1.20 [0.77-1.86],0.4160486235402496
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17892,260,0.92 [0.69-1.23],0.5821688271510257
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,18248,616,0.86 [0.71-1.04],0.1176279741652188
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,21965,308,0.92 [0.71-1.19],0.5292948771169488
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22959,82,0.92 [0.55-1.53],0.7484778234664997
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2633,82,1.46 [0.88-2.42],0.1383571148181466
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",20408,82,0.83 [0.50-1.38],0.4735928603802826
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,22379,139,0.98 [0.67-1.45],0.9252475575814966
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22316,76,0.99 [0.59-1.67],0.980733620852384
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",22448,80,0.92 [0.56-1.53],0.7483383018793601
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22689,100,1.00 [0.64-1.58],0.9865646779640797
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23289,143,0.58 [0.40-0.84],0.0039309656041256
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,22146,111,0.78 [0.51-1.20],0.2528597960445078
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,14401,4620,0.57 [0.52-0.63],9.922805581650282e-35
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,22423,97,1.04 [0.66-1.66],0.8534664725218571
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, essential",15267,3243,0.59 [0.53-0.65],5.1112080645443215e-27
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypertension,15311,3287,0.60 [0.54-0.66],4.0865666360079495e-26
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12136,112,0.83 [0.54-1.29],0.4160488708663621
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",20474,1844,0.55 [0.50-0.62],5.441069792389693e-25
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Angina pectoris,19727,1097,0.56 [0.49-0.64],5.459175481842947e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21985,349,0.66 [0.51-0.83],0.0006237204243267
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22337,701,0.56 [0.47-0.67],3.9923590511711395e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23217,132,0.53 [0.36-0.78],0.0011694531919855
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19066,436,0.47 [0.38-0.58],1.96083134717655e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,20101,1496,0.50 [0.45-0.57],4.3509489180597715e-28
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22227,137,1.31 [0.88-1.94],0.1796097048296243
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22450,280,1.21 [0.92-1.59],0.1740324973721203
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22207,117,0.92 [0.60-1.40],0.6927894722794949
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22208,118,0.93 [0.61-1.41],0.7262254101275296
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12137,113,0.79 [0.51-1.21],0.2740546190115404
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Cardiomyopathy,17168,71,0.90 [0.52-1.55],0.6999133713138367
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Conduction disorders,17269,172,0.74 [0.52-1.04],0.0823760135373733
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9119,144,0.60 [0.41-0.88],0.0087718579182472
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,9668,693,0.79 [0.66-0.96],0.0160464704061508
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other arrhythmias,17191,94,0.82 [0.52-1.31],0.4150035897916861
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,17221,124,0.83 [0.55-1.25],0.3644856517311695
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Heart failure, strict",21720,295,0.63 [0.48-0.82],0.0005082208150253
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22093,200,0.92 [0.66-1.26],0.5971155829497172
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22128,180,0.90 [0.64-1.26],0.5359177946463141
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22235,160,0.85 [0.60-1.22],0.3821159849593126
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21727,108,0.46 [0.30-0.70],0.0002855172380416
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,21797,178,0.42 [0.30-0.58],1.7324186174843589e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21653,165,1.12 [0.79-1.60],0.5239605206689351
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21631,143,1.00 [0.68-1.46],0.9902999832624222
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23104,137,0.91 [0.62-1.35],0.6427064747726362
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Varicose veins,22003,515,1.36 [1.11-1.67],0.0028760815378938
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypotension,21682,121,0.80 [0.53-1.21],0.2849528869016327
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,17233,2173,0.64 [0.57-0.71],8.782527181216346e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23220,77,0.93 [0.56-1.56],0.7894099324136641
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Influenza and pneumonia,20800,264,0.73 [0.55-0.97],0.0291998251887613
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",20772,236,0.76 [0.56-1.02],0.064290812527599
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22096,290,0.56 [0.43-0.73],1.8568134236532936e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22087,281,0.56 [0.43-0.73],2.013476616459523e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22650,552,0.74 [0.61-0.90],0.002490247704359
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Chronic sinusitis,22189,91,0.79 [0.49-1.26],0.3191757846946126
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Nasal polyp,22238,140,0.65 [0.44-0.94],0.0241536894855488
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22451,353,0.84 [0.66-1.07],0.1570491207807105
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Deviated nasal septum,22233,135,0.78 [0.53-1.15],0.2113769028279402
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7421,76,0.44 [0.26-0.74],0.0018110153055962
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,20249,1147,0.67 [0.58-0.77],1.251365843088154e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Early onset COPD,21709,246,0.53 [0.40-0.70],1.0328302719377978e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",21762,299,0.54 [0.42-0.70],2.443839109973926e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",21762,299,0.54 [0.42-0.70],2.443839109973926e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",21674,873,0.74 [0.64-0.87],0.0001898718600423
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Asthma,15207,873,0.64 [0.55-0.75],7.52012142748023e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",14810,873,0.64 [0.54-0.75],4.7327878634963975e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15198,864,0.64 [0.54-0.75],6.772875084411172e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,22810,125,0.45 [0.30-0.66],4.364979427014412e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Interstitial lung disease,21725,97,0.36 [0.23-0.56],4.670748449675456e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",22907,97,0.37 [0.24-0.57],5.58713414508572e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21718,90,0.38 [0.24-0.60],3.337554158022817e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pleural effusion,20547,145,0.64 [0.44-0.93],0.0178624091071247
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other diseases of pleura,20701,299,0.62 [0.48-0.80],0.0002827317874212
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,21683,135,0.82 [0.56-1.21],0.3219114896677553
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15095,6518,0.81 [0.75-0.87],5.2389347602298244e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22931,344,0.97 [0.76-1.24],0.8103055652073636
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23382,43,1.11 [0.55-2.22],0.7748500506292185
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Impacted teeth,23384,39,1.13 [0.54-2.34],0.7497155906757591
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Dental caries,22679,92,0.92 [0.58-1.48],0.7425884422271167
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22680,93,1.37 [0.86-2.20],0.1897522343009186
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23378,47,0.94 [0.48-1.82],0.8503797375366569
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22689,102,0.93 [0.59-1.46],0.7566195107597181
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22413,92,0.90 [0.56-1.44],0.6562937378326866
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23273,60,0.93 [0.52-1.66],0.7988292031999287
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16495,346,0.67 [0.53-0.86],0.0014004840939939
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",18752,2603,0.91 [0.83-1.00],0.0529169810451183
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Oesophagitis,16560,411,0.78 [0.62-0.98],0.0344310669911229
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,16993,844,1.04 [0.89-1.23],0.6138493118348123
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16237,88,0.98 [0.60-1.59],0.9253418233994584
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,16432,283,0.66 [0.50-0.86],0.0025602599307355
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Oesophageal obstruction,16233,84,0.67 [0.41-1.10],0.1155919319344892
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastric ulcer,16355,206,0.76 [0.56-1.05],0.0959531232571251
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Duodenal ulcer,16296,147,0.59 [0.41-0.85],0.0047730447427055
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23205,101,0.57 [0.37-0.89],0.0126136509648147
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Chronic gastritis,16297,148,1.05 [0.72-1.53],0.8055124853291072
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),17147,998,0.88 [0.76-1.03],0.1050931283188022
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of appendix,23247,90,1.33 [0.82-2.16],0.2484144334123198
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Functional dyspepsia,16639,490,1.05 [0.85-1.29],0.6590111482318839
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,16377,228,0.72 [0.53-0.97],0.0310368424339644
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23251,122,0.89 [0.59-1.35],0.5829300134855531
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute appendicitis,23234,77,1.29 [0.76-2.17],0.3482110222935742
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Hernia,19723,2095,0.68 [0.62-0.76],1.3841139414653442e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Inguinal hernia,18430,802,0.46 [0.39-0.54],5.352099620946872e-22
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Umbilical hernia,17765,137,0.60 [0.41-0.88],0.0092087661253249
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ventral hernia,17738,110,0.70 [0.45-1.08],0.1056642976027403
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,18772,1144,0.87 [0.76-1.00],0.0559798268316312
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22305,770,0.97 [0.82-1.14],0.7004136048986849
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of intestines,17120,2357,0.91 [0.83-1.01],0.08417443757379
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23027,44,0.97 [0.49-1.92],0.933200107220924
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23320,58,0.79 [0.44-1.43],0.445042653456802
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Crohn disease,21593,58,0.79 [0.44-1.44],0.4476831476656374
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21578,43,0.70 [0.35-1.38],0.3015443926466862
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23238,143,0.57 [0.39-0.82],0.0026726179862957
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ulcerative colitis,21678,143,0.57 [0.39-0.82],0.0027245191361165
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21668,133,0.58 [0.40-0.86],0.00627886878334
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22173,638,1.07 [0.89-1.28],0.4755875486273654
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22164,629,1.07 [0.89-1.28],0.504106237550977
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14892,129,0.80 [0.53-1.19],0.2613654031143851
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Intestinal stricture,22782,129,0.83 [0.56-1.24],0.3574137357498502
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14846,83,0.84 [0.51-1.37],0.480826385778258
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,15679,916,0.79 [0.68-0.92],0.0030063003346513
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14919,156,1.15 [0.80-1.67],0.4496674559869389
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,15089,326,0.91 [0.70-1.17],0.4487496612584013
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Constipation,21252,293,1.00 [0.76-1.30],0.9844663533089252
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of peritoneum,22889,95,1.29 [0.81-2.05],0.2848545768093287
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14869,106,0.96 [0.61-1.50],0.8498581389074615
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14818,55,0.62 [0.34-1.13],0.1199692834956894
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15743,980,0.90 [0.78-1.05],0.1903423276075768
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of intestine,15130,367,0.96 [0.75-1.22],0.7206676810190933
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22873,79,1.62 [0.98-2.70],0.0625008432593284
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of liver,22474,128,0.66 [0.44-0.98],0.0376447664175601
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of liver,22419,73,1.02 [0.60-1.74],0.9416152893106834
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",21873,736,1.06 [0.89-1.26],0.5118045373474751
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Cholelithiasis,21736,599,1.08 [0.90-1.31],0.4017754206372341
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Cholecystitis,21260,123,1.39 [0.92-2.10],0.1226273424529313
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21195,58,1.00 [0.55-1.82],0.9993730900364756
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute pancreatitis,21213,76,0.98 [0.58-1.66],0.9401876750683008
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23193,76,0.98 [0.58-1.65],0.9326469331925736
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of the digestive system,21857,345,0.82 [0.64-1.05],0.1107262848052461
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21588,76,1.87 [1.11-3.16],0.0189559525106431
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Coeliac disease,21577,65,1.73 [0.99-3.05],0.0563441872926633
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21570,58,0.79 [0.44-1.43],0.4449203628148988
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,21727,215,0.59 [0.44-0.80],0.0006506227901785
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,GI-bleeding,21718,206,0.57 [0.42-0.77],0.0003124005718199
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,19632,1628,0.89 [0.79-1.00],0.0589654492274766
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,22843,107,1.08 [0.70-1.68],0.7269056602315158
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22964,442,0.96 [0.77-1.19],0.6950283427535648
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,21271,630,1.03 [0.86-1.24],0.7376377155211704
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22318,393,0.61 [0.48-0.77],2.232602295521582e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21996,71,0.84 [0.49-1.42],0.5083778911122417
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22206,281,0.55 [0.42-0.72],1.6101872173102536e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23067,98,1.46 [0.92-2.32],0.1103005483604046
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23040,71,1.41 [0.82-2.43],0.2118276847914605
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23027,58,1.51 [0.83-2.74],0.1784274743173917
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,22945,80,0.77 [0.46-1.27],0.3016054434905518
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,22943,78,0.82 [0.49-1.38],0.4553190630120878
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22571,49,1.36 [0.71-2.61],0.3517421124849089
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22892,370,0.93 [0.73-1.18],0.5345302413658135
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20758,117,1.01 [0.66-1.54],0.955954272433858
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20745,104,1.24 [0.79-1.95],0.3488116249167489
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20712,71,0.86 [0.50-1.48],0.584674518420303
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",20872,231,1.05 [0.77-1.41],0.7699469750684221
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,20853,212,1.00 [0.73-1.37],0.9952785072985004
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,15276,4473,0.99 [0.91-1.07],0.7457919198991483
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,16889,2789,0.98 [0.89-1.08],0.7126239526024152
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,20732,1311,0.91 [0.80-1.04],0.1675469841516094
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14287,187,0.97 [0.69-1.35],0.8567843419018439
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14693,593,0.99 [0.82-1.20],0.9264192802184056
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22859,181,0.89 [0.63-1.25],0.4912802623560043
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22864,165,0.93 [0.65-1.33],0.7025217052887403
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,15755,1655,0.97 [0.86-1.09],0.5881912053260663
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",18313,1655,0.96 [0.85-1.08],0.5188060356427482
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14195,95,0.68 [0.43-1.09],0.1104373855981191
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",22599,92,0.67 [0.42-1.07],0.0945705031787436
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,14393,293,1.14 [0.87-1.49],0.3530644117135891
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14221,121,1.03 [0.68-1.57],0.8901286609610474
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,14541,441,1.08 [0.86-1.35],0.5049215247927826
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23158,218,1.13 [0.83-1.54],0.4431077027034255
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,14838,738,0.91 [0.76-1.09],0.310428086901768
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14671,571,0.98 [0.80-1.19],0.8164707061098236
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15445,1345,1.07 [0.94-1.22],0.2977505349690759
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14193,93,1.24 [0.77-2.01],0.376079165272367
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14399,299,1.56 [1.19-2.04],0.001319089270296
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14178,78,1.06 [0.63-1.80],0.8160435603011225
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14191,91,1.32 [0.81-2.14],0.2699934079740855
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14548,448,0.88 [0.71-1.10],0.2589953293937709
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14505,405,0.93 [0.74-1.18],0.5502303007581818
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17576,276,1.35 [1.02-1.79],0.0350499371220485
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22648,106,0.87 [0.56-1.36],0.5437605238423695
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22613,71,1.08 [0.63-1.86],0.7802866048311128
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19343,78,1.36 [0.81-2.30],0.246658881510663
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,19643,378,0.98 [0.77-1.24],0.8458609572289233
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,20224,959,1.00 [0.86-1.16],0.9825534714111006
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,19510,245,0.94 [0.70-1.27],0.699997019385795
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,19382,117,1.05 [0.68-1.60],0.8295120427110869
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",19969,704,0.99 [0.83-1.18],0.8843644432482181
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,19308,43,0.60 [0.30-1.19],0.1443629338143788
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,19484,219,1.03 [0.76-1.41],0.8314411323198109
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,19354,89,0.92 [0.57-1.49],0.7335986825610599
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,19351,86,0.83 [0.51-1.36],0.4616620251270821
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19397,132,0.96 [0.65-1.44],0.8584713194589146
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,19326,61,1.43 [0.79-2.58],0.2405542235966522
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19557,292,0.90 [0.68-1.17],0.4284116778193036
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19759,338,0.98 [0.76-1.26],0.8721470474453481
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19505,84,0.95 [0.58-1.55],0.833310023332789
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19540,119,1.41 [0.93-2.14],0.1098524446601795
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19509,88,0.80 [0.49-1.29],0.3506940853015289
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19463,42,0.85 [0.42-1.69],0.6357585966511274
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19588,167,0.83 [0.59-1.18],0.3058250218455564
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19577,156,0.90 [0.63-1.29],0.5609282332742769
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19719,298,0.81 [0.62-1.05],0.1150546583320156
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19478,57,1.20 [0.66-2.19],0.5452083704648878
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19522,101,0.60 [0.39-0.93],0.0234135775351569
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19563,142,0.94 [0.64-1.37],0.7400816866541492
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19473,52,1.35 [0.72-2.54],0.3486777056719382
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",19884,463,0.95 [0.77-1.18],0.6271902437649787
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,19613,192,0.89 [0.64-1.23],0.4791083541537017
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19678,257,1.02 [0.77-1.36],0.8853598307405603
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,20955,243,1.22 [0.91-1.64],0.189603974355729
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,21153,441,1.13 [0.91-1.41],0.2821798460907295
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20753,41,1.06 [0.52-2.19],0.8680453120830641
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20761,49,1.11 [0.58-2.15],0.7486191289103381
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20801,89,1.01 [0.62-1.64],0.9697069269419762
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,17039,4124,1.07 [0.99-1.16],0.1006871460132303
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,9016,875,1.00 [0.85-1.19],0.9546112219991194
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19608,300,0.61 [0.47-0.79],0.0001532501957985
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19391,83,0.54 [0.33-0.88],0.0123409445159005
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Acute renal failure,19660,65,0.61 [0.35-1.07],0.0831131948978882
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,19688,93,0.65 [0.41-1.03],0.0679491430246216
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19675,80,0.56 [0.34-0.91],0.0202520259386635
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23005,252,0.53 [0.40-0.70],7.491138111564427e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,22773,93,1.03 [0.64-1.64],0.9142872679005688
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22940,187,0.56 [0.40-0.77],0.0003958876279942
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22829,76,0.53 [0.32-0.87],0.0128484231471723
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,20414,1219,0.88 [0.77-1.00],0.0562671633978536
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Cystitis,19310,115,0.96 [0.63-1.47],0.8452396071499026
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,19291,96,1.09 [0.69-1.75],0.7060639077158313
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,19567,372,0.64 [0.51-0.82],0.0002626570317156
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Urethral stricture,19339,144,0.67 [0.46-0.98],0.036672098354861
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,19938,743,0.98 [0.82-1.16],0.8011933129544533
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8641,500,0.99 [0.79-1.23],0.9168673010314
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8212,71,1.06 [0.60-1.86],0.8529244254269152
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Hydrocele,8204,63,1.01 [0.55-1.84],0.981259092438173
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8213,72,1.24 [0.70-2.18],0.4555187126235513
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8237,96,1.25 [0.76-2.04],0.3755459810698626
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8254,113,0.84 [0.54-1.32],0.4546519062316376
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Disorders of breast,12085,231,1.33 [0.97-1.82],0.0797417730395165
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11931,77,2.09 [1.22-3.58],0.0073473292151012
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,11935,81,0.81 [0.48-1.37],0.4382700100546943
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11912,58,1.23 [0.66-2.29],0.5103112627765478
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12058,166,0.87 [0.60-1.25],0.4498477677743949
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,11942,50,1.02 [0.52-2.02],0.9441874583973237
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11949,57,0.99 [0.53-1.86],0.9821584243971782
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,11174,1827,0.93 [0.83-1.05],0.260638863160515
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Endometriosis,9410,63,1.15 [0.63-2.10],0.6511953104969643
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9398,51,1.10 [0.56-2.15],0.7803769352637839
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9840,493,0.75 [0.61-0.94],0.0101602502109337
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9454,107,0.83 [0.53-1.31],0.4198730681609904
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9833,486,1.02 [0.82-1.27],0.8733197443321139
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9497,150,0.99 [0.67-1.46],0.951724372998303
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9569,222,1.24 [0.90-1.71],0.1924000218614665
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,9364,17,0.69 [0.23-2.11],0.5191491361169529
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,9394,47,0.64 [0.33-1.25],0.195305748904065
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",12208,63,0.58 [0.33-1.03],0.0636472836383217
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,12210,58,0.56 [0.31-1.02],0.0570687099394216
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,12216,29,0.38 [0.18-0.81],0.0121260146079625
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",12214,33,0.44 [0.21-0.92],0.030126756203377
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9421,74,0.99 [0.57-1.73],0.9786654769670092
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9400,53,0.93 [0.49-1.78],0.8235572732569854
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9415,68,1.23 [0.69-2.18],0.4839761924922414
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Irregular menses,12215,87,0.76 [0.46-1.26],0.2923839655080907
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",9542,195,0.81 [0.58-1.15],0.2378684954427219
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Menorrhagia,9438,91,0.94 [0.56-1.56],0.8013295698755907
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",12217,37,0.69 [0.32-1.50],0.3463995741749774
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9459,112,0.68 [0.44-1.06],0.0886218407193931
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9394,47,0.60 [0.31-1.14],0.118147160523779
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9987,640,1.12 [0.92-1.36],0.2552367422652879
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",22826,87,0.64 [0.40-1.03],0.0666727466114214
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19915,670,1.19 [0.99-1.42],0.0637287617548033
